Pharmacy

For pharmacy and clinical informatics leaders, the “build-versus-buy” conundrum has become the default starting point for AI technology decisions. In medication workflows, however, that framing is incomplete. Whether an organization builds internally, buys from a vendor, or extends its EHR,…

Florida Attorney General James Uthmeier has filed a lawsuit against Prime Therapeutics LLC and Express Scripts, alleging the pharmacy benefit managers entered into an illegal horizontal price-fixing agreement that threatens access to affordable medications. The lawsuit alleges the competitors entered…

Becker’s asked pharmacy executives from hospitals and health systems, along with academic medical centers and universities across the U.S. to share what trends they deem dangerous. The 18 executives featured in this article are all speaking at Becker’s Healthcare 3rd…

The FDA has approved Lisraya (brepocitinib) tablets for adults with dermatomyositis, marking the first FDA-approved oral treatment for the rare autoimmune disease. The approval was based on a phase 3 randomized, double-blind, multicenter, placebo-controlled study involving 241 adults, according to…

The U.S. Court of Appeals for the Fifth Circuit affirmed a lower court’s ruling in favor of HHS and CMS on Aug. 26, upholding the Medicare Drug Price Negotiation Program against a constitutional challenge from PhRMA, the National Infusion Center…

The U.S. shortage of the chemotherapy drug ifosfamide has reached a “critical” stage, according to an Aug. 25 news release from the American Society of Clinical Oncology.  To address the shortage, the FDA is allowing overseas manufacturers to temporarily import…

The Association of American Medical Colleges (AAMC) and the American Hospital Association (AHA) filed separate comment letters this week targeting the 340B fight — AAMC on CMS’s Medicare Drug Price Negotiation Program rule, AHA on Sen. Bill Cassidy’s 340B Drug…

The FDA has approved Rasonque (daraxonrasib) for adults with advanced pancreatic cancer that has stopped responding to earlier treatment, or for patients too sick for standard combination chemotherapy. The drug improved median overall survival to 13.2 months compared with just…

CMS is investing $3.15 million to strengthen pharmacy connectivity and care coordination across Ohio’s 73 rural counties through the Rural Health Transformation Program. The funding will connect independent and retail pharmacies, federally qualified health centers and outpatient hospital pharmacies to…

Vitruvias Therapeutics is voluntarily recalling one lot of Thyroid Tablets, USP 30 milligrams after testing found the product could be more potent than intended. The consumer-level recall covers Lot 504950, which was distributed nationwide to Vitruvias Therapeutics’ direct accounts from…